|
|
| (One intermediate revision by one other user not shown) |
| Line 1: |
Line 1: |
| __NOTOC__
| | #REDIRECT [[Amyl nitrite#Warnings]] |
| {{Amyl nitrite}}
| |
| {{CMG}}; {{AE}} {{PB}}
| |
| | |
| | |
| ==Warnings==
| |
| | |
| Transient episodes of [[dizziness]], weakness, or [[syncope]] or other signs of [[cerebral ischemia]] due to [[postural hypotension]] may develop following inhalation of amyl nitrite, particularly if the patient is standing immobile. To hasten recovery, measures which facilitate venous return such as head low posture, deep breathing and movement of extremities may be used.
| |
| | |
| | |
| ==Precautions==
| |
| | |
| Amyl nitrite is very flammable. Do not use where it might become ignited. General - Tolerance to amyl nitrite may develop with repeated use of the drug for prolonged periods of time. Tolerance may be minimized by beginning with the smallest effective dose and alternating the drug with another coronary [[vasodilator]]. High doses of nitrites may produce [[methemoglobinemia]], especially in individuals with methemoglobin reductase deficiency or other metabolic abnormality that interferes with the normal conversion of methemoglobin back to hemoglobin.<ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = AMYL NITRITE INHALANT [JAMES ALEXANDER CORPORATION] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c1b6e536-df5f-4f76-8e3c-6dc2f1e9975e | publisher = | date = | accessdate = 30 January 2014 }}</ref> | |
| | |
| ==References==
| |
| | |
| {{Reflist|2}}
| |
| | |
| [[Category:Drugs]]
| |